September 18, 2026 · Gut · DOI: 10.1136/gutjnl-2026-339071

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC

Listen to this summary

The authors investigate the mechanisms and immune features that influence the response to neoadjuvant PD-L1 blockade in oesophageal squamous cell carcinoma (ESCC). By analyzing single-cell and spatial transcriptomes, they identify specific cellular programmes linked to treatment efficacy and highlight the role of lymphocyte activation gene 3 as a potential target to enhance responses in non-responders. Their findings aim to inform personalized immunotherapy strategies for ESCC.

Si Li, Jiyu Guo, Jianqun Ma, Jiaxin Yang, Zuxiang Wang, Gang Xu, Yun Yu, Kang Xu, Yueying Gao, Weiwei Zhou, Can Zhang, Qinghua Jiang, Xiaoyuan Wang, Hang Yin, Yongsheng Li

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play